» Articles » PMID: 16537545

Contrasting Effects of EWI Proteins, Integrins, and Protein Palmitoylation on Cell Surface CD9 Organization

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2006 Mar 16
PMID 16537545
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

CD9, a tetraspanin protein, makes crucial contributions to sperm egg fusion, other cellular fusions, epidermal growth factor receptor signaling, cell motility, and tumor suppression. Here we characterize a low affinity anti-CD9 antibody, C9BB, which binds preferentially to homoclustered CD9. Using mAb C9BB as a tool, we show that cell surface CD9 homoclustering is promoted by expression of alpha3beta1 and alpha6beta4 integrins and by palmitoylation of the CD9 and beta4 proteins. Conversely, CD9 is shifted toward heteroclusters upon expression of CD9 partner proteins (EWI-2 and EWI-F) or other tetraspanins, or upon ablation of CD9 palmitoylation. Furthermore, unpalmitoylated CD9 showed enhanced EWI-2 association, thereby demonstrating a previously unappreciated role for tetraspanin palmitoylation, and underscoring how depalmitoylation and EWI-2 association may collaborate to shift CD9 from homo- to heteroclusters. In conclusion, we have used a novel molecular probe (mAb C9BB) to demonstrate the existence of multiple types of CD9 complex on the cell surface. A shift from homo- to heteroclustered CD9 may be functionally significant because the latter was especially obvious on malignant epithelial tumor cells. Hence, because of its specialized properties, C9BB may be more useful than other anti-CD9 antibodies for monitoring CD9 during tumor progression.

Citing Articles

Inhibition of HIV-1 replication by nanobodies targeting tetraspanin CD9.

Umotoy J, Kroon P, Man S, van Dort K, Atabey T, Schriek A iScience. 2024; 27(10):110958.

PMID: 39391729 PMC: 11465043. DOI: 10.1016/j.isci.2024.110958.


TSPAN1 inhibits metastasis of nasopharyngeal carcinoma via suppressing NF-kB signaling.

Wang M, Li H, Peng L, Mei Y, Zheng L, Li C Cancer Gene Ther. 2023; 31(3):454-463.

PMID: 38135697 DOI: 10.1038/s41417-023-00716-w.


Tetraspanins set the stage for bone marrow microenvironment-induced chemoprotection in hematologic malignancies.

Quagliano A, Gopalakrishnapillai A, Barwe S Blood Adv. 2023; 7(16):4403-4413.

PMID: 37561544 PMC: 10432613. DOI: 10.1182/bloodadvances.2023010476.


Prognostic value and multifaceted roles of tetraspanin CD9 in cancer.

Ondrussek R, Kvokackova B, Krystofova K, Brychtova S, Soucek K, Bouchal J Front Oncol. 2023; 13:1140738.

PMID: 37007105 PMC: 10063841. DOI: 10.3389/fonc.2023.1140738.


EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancy.

Ding Y, Chen J, Li S, Wren J, Bajpai A, Wang J Oncogene. 2023; 42(12):861-868.

PMID: 36788350 DOI: 10.1038/s41388-023-02623-8.